Search

Your search keyword '"Sambatakou, H."' showing total 275 results

Search Constraints

Start Over You searched for: Author "Sambatakou, H." Remove constraint Author: "Sambatakou, H."
275 results on '"Sambatakou, H."'

Search Results

1. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration

2. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration

3. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

4. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

5. Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

7. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

8. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

9. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

10. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

11. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

12. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

13. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

14. Evaluation of the Dynamiker® Fungus (1–3)-β-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies

15. HIV continuum of care: Bridging cross-sectional and longitudinal analyses

16. Dating the Origin and Estimating the Transmission Rates of the Major HIV‐1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe

17. Observational cohort study of rilpivirine (RPV) utilization in Europe

18. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

19. The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy

20. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

21. Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece

22. Population pharmacokinetics of anidulafungin in ICU patients assessing inter- and intrasubject variability

23. A prospective multicenter cohort surveillance study of invasive aspergillosis in patients with hematologic malignancies in greece: impact of the revised eortc/msgerc 2020 criteria

24. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

25. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

26. Correction to: The mystery of 'missing' visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital (Clinical Research in Cardiology, (2020), 109, 12, (1483-1489), 10.1007/s00392-020-01682-1)

27. A nationwide study about the dispersal patterns of the predominant HIV-1 subtypes A1 and B in Greece: Inference of the molecular transmission clusters

28. Clinical characteristics and outcomes of measles outbreak in adults: A multicenter retrospective observational study of 93 hospitalized adults in Greece

29. Population pharmacokinetics of micafungin over repeated doses in critically ill patients: a need for a loading dose?

30. Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece

31. Comparative pharmacokinetics of the three echinocandins in ICU patients

32. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons

33. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

40. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

42. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

43. The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy

45. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

47. The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort

48. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

49. Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis

50. HIV cascade of care in Greece: Useful insights from additional stages

Catalog

Books, media, physical & digital resources